Posted: 19 June 2023 Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) to add positive data from the Phase 3 VALOR-HCM study to the U.S.…
Posted: 19 June 2023 A pioneering radiotherapy treatment developed at Peter Mac is emerging as a new treatment option for cancer that has spread to the lungs, following exciting results in a recent study. Long-term survival data is…
Posted: 19 June 2023 Telix today announces that the first patient has been dosed in a Phase II study of the Company’s carbonic anhydrase- (CAIX)-targeting PET/CT[1] imaging agent TLX250-CDx (89Zr-DFO-girentuximab), exploring this potential target across a broad range of…
Posted: 15 June 2023 Melbourne researchers have used heart and lung stem cells infected with the virus that causes COVID-19 to better understand how the disease impacts different organs, paving the way for more targeted treatments. The research,…
Posted: 15 June 2023 Telix Pharmaceuticals has topped the inaugural Financial Review Fast Global list, with international revenue growth at the Melbourne-based, cancer-fighting biotech soaring off the back of a drug approval in the US. The Fast Global…
Posted: 13 June 2023 Telix today welcomes Willy Borsus, Vice-President of Wallonia, Minister of Economy, Research and Innovation, Digital, Agriculture, Urban Planning and Regional Planning to officially open Telix Manufacturing Solutions, the Company’s radiopharmaceutical production facility located in…
Posted: 13 June 2023 Today, in the presence of Australia’s Prime Minister, the Honourable Anthony Albanese MP, RMIT University announced the next phase of its Country Commitment to Vietnam, including a AUD $250 million strategic investment fund. The…
Posted: 13 June 2023 Breakthrough Victoria is investing $10 million towards a new world-leading eye clinical trials centre that will provide Victorians with early access to new treatments aiming to prevent and cure blindness. The new eye clinical…
Posted: 9 June 2023 ARCS Australia has released a white paper to define common terms used in decentralised clinical trials providing a common and consistent language for the sector. The paper was released on day two of the…
Posted: 9 June 2023 Kinoxis Therapeutics is pleased to announce it has been awarded a UH3 grant by the National Institute on Drug Abuse (NIDA), part of the US National Institutes of Health (NIH), which is expected to…
Posted: 9 June 2023 Australia’s national science agency, CSIRO, has invested $25 million up to 2027 in a new program that will harness the building blocks of life to solve intractable problems. Advanced Engineering Biology (AEB) is the latest…
Posted: 9 June 2023 Avecho Biotechnology Limited today announced it has completed the development of first generation TPM® gummies containing cannabinoids. TPM cannabinoid gummies out–perform standard products with faster onset and greater magnitude of effect.Gummies are chewable, jelly–like preparations made…